SAB Biotherapeutics (SABS) Shares Outstanding (Diluted) (2020 - 2026)
SAB Biotherapeutics (SABS) reported Shares Outstanding (Diluted) of 79.75 million for Q2 2026, up 758.1% from 9.29 million a year earlier and up 48.9% from the prior quarter.
SAB Biotherapeutics (SABS) Shares Outstanding (Diluted) (2020 - 2026) Analysis & Trends
For FY2025, SAB Biotherapeutics posted Shares Outstanding (Diluted) of 61.34 million, up 562.3% from FY2024.
- Shares Outstanding (Diluted) has increased for five consecutive years, with a five-year compound annual growth rate of 86.7% (FY2020 to FY2025).
- By year, Shares Outstanding (Diluted) came in at 9.26 million in FY2024 (+67.7%), 5.52 million in FY2023 (+26.9%), 4.35 million in FY2022 (+59.2%) and 2.73 million in FY2021 (+1.2%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Diluted) in data going back to Q4 2020.
- Year over year, Shares Outstanding (Diluted) has now increased in each of the last 19 quarters, with growth averaging 335.4% over the last eight quarters.
- The year-over-year growth in Shares Outstanding (Diluted) has ranged between 0.4% (Q2 2025) and 758.1% (Q2 2026) over the last five years.
- Per Business Quant data, the three quarters before Q2 2026 came in at 53.56 million (Q1 2026), 61.34 million (Q4 2025) and 77.86 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.44 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 1.96 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 1.56 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 544.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 255.20 Mn |
| 10 | SAB Biotherapeutics | 264.67 Mn | 264.67 Mn | - | 79.75 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 79.75 Mn |
| Mar 31, 2026 | 53.56 Mn |
| Dec 31, 2025 | 61.34 Mn |
| Sep 30, 2025 | 77.86 Mn |
| Jun 30, 2025 | 9.29 Mn |
| Mar 31, 2025 | 9.29 Mn |
| Dec 31, 2024 | 9.26 Mn |
| Sep 30, 2024 | 9.26 Mn |
| Jun 30, 2024 | 9.26 Mn |
| Mar 31, 2024 | 9.24 Mn |
| Dec 31, 2023 | 5.52 Mn |
| Sep 30, 2023 | 5.24 Mn |
| Jun 30, 2023 | 5.04 Mn |
| Mar 31, 2023 | 5.04 Mn |
| Dec 31, 2022 | 4.35 Mn |
| Sep 30, 2022 | 4.30 Mn |
| Jun 30, 2022 | 4.30 Mn |
| Mar 31, 2022 | 4.58 Mn |
| Dec 31, 2021 | 2.73 Mn |
| Sep 30, 2021 | 2.60 Mn |
SAB Biotherapeutics Shares Outstanding (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SABS&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-diluted", "ticker": "SABS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-diluted&ticker=SABS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();